JW (Cayman) Therapeutics Co. Ltd (JWCTF)

Revenue by Product

Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Anti-tumor Drugs	192.11M	Log In	Log In
Anti-tumor Drugs Growth	13.38%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
China	192.11M	Log In	Log In
China Growth	13.38%	Log In	Log In